Multi-disciplinary surgical approach to the management of patients with renal cell carcinoma with venous tumor thrombus: 15 year experience and lessons learned
Authors:
- Bishoy A. GayedBGBishoy A. Gayed
- Ramy YoussefRYRamy Youssef
- Oussama DarwishODOussama Darwish
- Payal KapurPKPayal Kapur
- Aditya BagrodiaABAditya Bagrodia
- James BrugarolasJBJames Brugarolas
- Ganesh RajGRGanesh Raj
- J. Michael DiMaioJDJ. Michael DiMaio
- Arthur SagalowskyASArthur Sagalowsky
- Vitaly MargulisVMVitaly Margulis
Open Access
- 19 July 2016
- journal article
- research article
- Published by Springer Nature in BMC Urology
- Vol. 16 (1) , 1-8
Abstract
The management of patients with renal cell carcinoma (RCC) with venous tumor thrombus (VTT) is challenging. We report our 15 year experience in the management of patients with RCC with VTT utilizing a multidisciplinary team approach, highlighting improved total and specifically Clavien III-V complication rates. We reviewed the records of 146 consecutive patients who underwent radical nephrectomy with venous thrombectomy between 1998 and 2012. Data on patient history, staging, surgical techniques, morbidity, and survival were analyzed. Additionally, complication rates between two surgical eras, 1998–2006 and 2006–2012, were assessed. The study included 146 patients, 97 males (66 %), and a median age of 61 years (range, 24–83). Overall complications rate was 53 %, high grade complications (Clavien III -V) occurred in 10 % of patients. Most importantly, there was a lower incidence of overall and high grade complications (45 % and 8 %, respectively) in the last 6 years compared to the earlier surgeries included in the study (67 % and 13 % respectively) [p = .008 and .03, respectively). 30 day postoperative mortality was 2.7 %. 5 year overall survival (5Y- OS) and 5 year cancer specific survival (5Y- CSS) were 51 % and 40 %, respectively. Metastasis was the only independent predictor factor for CSS (HR 3.8, CI 1.9-7.6 and p < .001) and OS (HR 2.6, CI 1.5-4.7 and p = .001) in all patients. Our data suggest that patients with RCC and VTT can be treated safely utilizing a multidisciplinary team approach leading to a decrease in complication rates.Keywords
This publication has 28 references indexed in Scilit:
- Tumor thrombus of inferior vena cava in patients with renal cell carcinoma – clinical and oncological outcome of 50 patients after surgeryBMC Research Notes, 2012
- Contemporary Management of Renal Tumors With Venous Tumor ThrombusJournal of Urology, 2010
- Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcomeBJU International, 2009
- Surgery Insight: management of renal cell carcinoma with associated inferior vena cava thrombusNature Reviews Endocrinology, 2008
- RENAL CELL CARCINOMA WITH RENAL VEIN AND INFERIOR VENA CAVAL INVOLVEMENT: CLINICOPATHOLOGICAL FEATURES, SURGICAL TECHNIQUES AND OUTCOMESJournal of Urology, 2005
- Classification of Surgical ComplicationsAnnals of Surgery, 2004
- The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombusBJU International, 2004
- Prognostic Significance of Tumor Thrombus Level in Patients With Renal Cell Carcinoma and Venous Tumor Thrombus Extension. Is All T3b the Same?Journal of Urology, 2004
- Renal Cell Carcinoma With Retroperitoneal Lymph Nodes: Role of Lymph Node DissectionJournal of Urology, 2003
- Long-Term Followup After Surgical Treatment for Renal Cell Carcinoma Extending into the Right AtriumJournal of Urology, 1996